세계의 얼굴용 주입제(보톡스) 시장 규모 : 제품별, 용도별, 지역별, 범위 및 예측

Facial Injectables Market Size And Forecast

Facial Injectables Market size was valued at USD 5,746.05 Million in 2021 and is projected to reach USD 23,448.23 Million by 2030 , growing at a CAGR of 16.91% from 2023 to 2030. The most common uses for facial injectables are to alleviate early indications of aging and to enhance aesthetic appeal. Collagens, hyaluronic acids, polymers, and botulinum toxins are some of the most regularly utilized facial injectables. The popularity of face injectable treatment for skin fold reduction, skin smoothening, lip augmentation, wrinkle elimination, acne treatment, scar treatment, and other applications is driving the market adoption of facial injectables. In the following study, the usage of face Injectables for the treatment of paralyzed vocal cords is being considered by the US FDA for approval, which is projected to boost the Facial Injectables Market's growth.

Global Facial Injectables Market Definition

Dermal fillers are another name for facial injectables. Facial injectables include collagen, calcium hydroxyapatite, and hyaluronic acid-based treatments that rejuvenate the facial skin by performing a variety of tasks such as wrinkle removal and reduction, lip enhancement, scar elevating, and soft tissue volume reduction. Filling the target area with facial injectables soothes wrinkles and scars on the face. Anti-wrinkle injections relax the muscles that produce wrinkles, while dermal fillers minimize wrinkles and add volume to the cheeks and lips.

Dermal fillers are injected directly into the wrinkles, while anti-wrinkle injections relax the muscles that generate wrinkles. Fillers are constructed of sugar molecules or hyaluronic acids, collagens (that can come from swine, cows, and cadavers, or be synthesized in a lab), the patient's fat, and synthetic polymers. Calcium hydroxyapatite, polyamide, polyacrylate, and polylactic acid are examples of the latter. The "Artiste Assisted Injection System" was introduced to the US market in 2012 to help in dermal filler distribution.

The injecting device can reduce patient discomfort and adverse events by managing the rate of filling of the injection which is being used by the physician to fill in the lip and frown lines. Bruising, redness, discomfort, and itching are all frequent side effects of a botched dermal filler operation. Infection or allergic reactions are fewer common causes of scarring and tumors. Serious side effects such as blindness from retrograde (abrupt) embolization of the ophthalmic and retinal veins have been reported on a more uncommon basis.

The industry makes use of technological breakthroughs. Antioxidant epidermal patches are now being developed at a high level of innovation. The use of a microneedle on the bottom of the patches penetrates the skin, allowing antioxidants to go deep into the skin. These patches could be a better, faster approach to calming and lightening your skin at home. Patches with better antioxidant penetration will reach their full potential, allowing them to give the wrinkle-smoothing and skin-brightening benefits we want. Providing a variety of future chances for the sector.

Global Facial Injectables Market Overview

The sector has been discovered to be flourishing, with an increase in the size of the Facial Injectables Market. Non-surgical market treatments, facial injectable fillers, and wrinkle relaxer injectables have all seen a three-fold increase. Non-invasive aesthetic procedures will grow the market during the projection period. Skin damage is caused by pollution and numerous lifestyle choices, which drive up demand during the projection period. Collagen fibers, hyaluronic acid fillers, and synthetic fillers are used to make facial injectables. This cream moisturizes and enhances your skin while also protecting it from UV damage and having minimal negative effects.

The market for face injectables is driven by all of the aforementioned criteria. Furthermore, the growing number of plastic surgeons and their networks is driving demand for aesthetic procedures, which is boosting demand for face injectables. There was also FDA authorization for other practitioners, including dentists, to utilize face Injectables in their clinics. Dentists can now perform face injectable procedures because they encounter many patients requiring facial transformation after dental treatments. The market for facial injectables is likely to develop as a result of this.

In addition, advances in treatments and materials, as well as changes in patient demographics, are assisting physicians and dermatologists in treating diverse facial areas. These innovations help physicians and dermatologists create customized treatments for patients and make it easier to use combination products to achieve better outcomes, propelling the worldwide Facial Injectables Market. All of these factors are expected to contribute to the market's future growth. Amplified products like HA (Hyaluronic Acid) and BoNTA (Botulinum Toxin Type A) fillers are used in conjunction to improve outcomes, especially in the lower facial processes.

This also fuels the worldwide Facial Injectables Market's expansion. The capacity of face injectables, major market parameters, year-over-year growth rate, and manufacturer market share are all aspects that influence the industry's opportunities. The growth is restricted by tight regulatory concerns and limits on the items, as well as skin problems such as rashes and redness. Rather than aesthetic applications, the market's expansion will be hampered by several market-hindering factors in the future projection year. Filler prices are too high, limiting expansion and, as a result, market size. The negative effects of dermal fillers are also a major issue limiting the size of the facial injectable business.

Global Facial Injectables Market Segmentation Analysis

The Global Facial Injectables Market is segmented on the basis of Product, Application, and Geography.

Facial Injectables Market, By Product

• Botulinum Toxin Type A
• Calcium Hydroxylapatite (CaHA)
• Collagen
• Hyaluronic Acid (HA)
• Polymer Fillers

Based on Product, the market is bifurcated into Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Collagen, Hyaluronic Acid (HA), and Polymer Fillers. The hyaluronic acid segment dominated the market, and it is predicted to increase at a healthy rate over the next few years. The increasing use of hyaluronic acid in the cosmetics industry is likely to fuel growth. Because of its high-water retention qualities and low allergic reactions, hyaluronic acid has become a staple in cosmetics. Hyaluronic acid segment growth includes a moisture-binding feature that helps preserve and enhance the vital moisture held to account for the plumpness of the facial skin. The segment's rise is fuelled by growing demands for cosmetic surgeries and an increase in the number of facial surgeries done.

Facial Injectables Market, By Application

• Therapeutics
• Aesthetics

Based on Application, the market is bifurcated into Therapeutics and Aesthetics. Increasing use of facial injectables for aesthetic procedures such as treatment of parentheses lines, wrinkles on the face, lip lines, lip augmentation, lip border restoration, perioral lines, crow's feet lines, frown lines, glabellar lines, filling furrows (deep wrinkles), periorbital wrinkles, superficial lines, acne scars, tear troughs, marionette lines, lipoatrophy of the face, nasopharyngeal. In the future years, demand for facial injectables for cosmetic purposes is predicted to rise due to a growing interest in physical appearance and income growth among middle-class people in developing nations such as India.

Facial Injectables Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Regional Analysis, the Global Facial Injectables Market is classified into North America, Europe, Asia Pacific, and Rest of the world. North America led the market in 2020, accounting for more than 41.0 percent of total sales. The high elderly population in the United States and Canada is expected to drive demand for face injectables over the projected period. Botox injections were discovered to have jumped by 845 percent. As a result, in the coming years, North America is likely to be a major income generator for facial injectables. The Asia Pacific market is expected to increase at a quick rate. Among the countries that help the region are India, Australia, and South Korea. In these developing countries, a growing emphasis on physical attractiveness is projected to drive the desire for facial injectable treatments. India is expected to be the largest economy in the world by 2050.

Key Players

• The "Global Facial Injectables Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Suneva Medical Inc., ALLERGAN, Bloomage BioTechnology Corporation Limited, Ipsen, Merz Pharma, Anika Therapeutics Inc., Medytox Inc, Galderma S.A, Prollenium Medical Technologies Inc, Sinclair Pharma.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• The International Society of Aesthetic Plastic Surgery in the United States came in first for non-surgical product discovery. Botulinum toxin and hyaluronic acid were the most well-known injectables identified so far.
• In June 2020, For persons above the age of 21, to reduce wrinkles The FDA granted Allergan Aesthetics approval to develop a variety of cosmetic products. It also acquired FDA approval for the use of hyaluronic acid gel for cheeks to treat age-related disorders from the Food and Drug Administration.
• In August 2018, Antares Pharma and Pfizer Inc. collaborated to develop the rescue pen, an injectable medication device.
• HUMIRA Pen, face injectable fillers, is utilized for human anti-tumor necrosis factor-alpha monoclonal antibodies in the Facial Injectables Market forecast. Patients with rheumatoid arthritis use this injectable medicine, which increases its market demand.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL FACIAL INJECTABLES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL FACIAL INJECTABLES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model

5 GLOBAL FACIAL INJECTABLES MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Botulinum Toxin Type A
• 5.3 Calcium Hydroxylapatite (CaHA)
• 5.4 Collagen
• 5.5 Hyaluronic Acid (HA)
• 5.6 Polymer Fillers

6 GLOBAL FACIAL INJECTABLES MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Therapeutics
• 6.3 Aesthetics

7 GLOBAL FACIAL INJECTABLES MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL FACIAL INJECTABLES MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Suneva Medical, Inc.
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 ALLERGAN
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Bloomage BioTechnology Corporation Limited
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Ipsen
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Merz Pharma
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Anika Therapeutics, Inc.
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Medytox, Inc.
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Galderma S.A.
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Prollenium Medical Technologies Inc.
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Sinclair Pharma
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research